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Hepatitis C virus (HCV) core protein has many intriguing properties as a viral factor and is implicated in cell growth
regulation. In this study, the cell growth regulation potential of HCV core protein was investigated by introduction of the core
genomic region into primary human hepatocytes, a natural host for virus replication and tropism. Core-transfected primary
human hepatocytes displayed altered cell morphology resembling that of low-differentiated epithelial cells. Those cells
retained an immortalized phenotype and exhibited continuous growth after more than 50 passages over 2 years. Stable
hepatocyte transfectants exhibited albumin secretion and HCV core protein expression. Telomerase activity, a characteristic
of immortalized or transformed cells, was evident in the transfected hepatocytes immediately after senescence. Anchorage-
independent growth of the immortalized hepatocytes provided further evidence for a transformed phenotype. Results from
these studies suggest that the HCV core protein promotes primary human hepatocytes to an immortalized phenotype, which
may predispose cells over an extended period of time to undergo a transforming event. Thus, HCV core protein appears to
contribute to virus-mediated pathogenesis in a persistently infected host. © 2000 Academic PressINTRODUCTION
Hepatitis C virus (HCV) is an important cause of mor-
bidity and mortality worldwide, causing a spectrum of
liver disease ranging from an asymptomatic carrier state
to end-stage liver disease. The most important feature of
persistent HCV infection is the development of chronic
hepatitis and the potential for disease progression to
hepatocellular carcinoma (Saito et al., 1990; Alter, 1996;
Idilman et al., 1998). The genomic region encoding a
protein from the amino terminal (amino acids 1–191) of
HCV is believed to be a core protein due to homology
with related viruses. Growing evidence suggests that the
core protein has many intriguing functional properties
and has been implicated as a viral factor in pathogenesis
(Shih et al., 1993, 1995; D. W. Kim et al., 1994; Lo et al.,
1995; Ray et al., 1995, 1997, 1998; Matsumoto et al., 1997;
sieh et al., 1998; Yasui et al., 1998; Shrivastava et al.,
998; You et al., 1999; Mamiya and Worman, 1999; Ow-
ianka and Patel, 1999; Lu et al., 1999). Transfection of
CV core gene together with H-ras as a cooperative
ncogene has been observed to transform primary rat
mbryo fibroblasts to a tumorigenic phenotype (Ray et
l., 1996b). A similar observation has been also noted
fter transfection of the core gene into murine fibroblasts
Chang et al., 1998; Tsuchihara et al., 1999). Expression of
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ouis University Health Sciences Center, 3635 Vista Avenue, FDT-8N,
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197HCV core protein leads to the development of progres-
sive hepatic steatosis (fatty change) and hepatocellular
carcinoma in two independent lines of transgenic mice
(Moriya et al., 1997, 1998).
HCV is a typical RNA virus, and there is no evidence of
integration of the viral genome into host chromosomes.
Oncogenesis is a multistep process and thus makes it
difficult to understand the precise mechanism of trans-
formation at the cellular level. HCV gene expression that
is unique to permissive natural host cells may influence
the magnitude or spectrum of core protein activity. In this
study, the core genomic region was introduced into pri-
mary human hepatocytes to study its ability to affect cell
growth regulation.
RESULTS
Growth properties and morphology of HCV core
gene-transfected primary human hepatocytes
The immortalization potential of the HCV core protein
was investigated by transfection of primary human hepa-
tocytes, a natural host for HCV infection, with a core
expression plasmid. Cells from three different donors
were transfected with a plasmid construct of the
genomic region under the control of a CMV early pro-
moter or an antisense orientation of the plasmid DNA or
empty vector DNA as negative controls. Transfected
cells were maintained in serum-free culture medium at
32°C in a CO2 incubator and passaged at a 3- to 4-day
intervals for the first 20 days. Cells transfected with the
antisense orientation of the HCV core or empty vector
0042-6822/00 $35.00
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198 RAY, MEYER, AND RAYDNA as a negative control failed to exhibit growth after
senescence (crisis period), which continued for about
12–16 weeks, at which time the cells began to degener-
ate. In contrast, hepatocytes transfected with core plas-
mid DNA replicated autonomously in primary culture at a
frequency of 1.0–1.5 3 1024 after a senescence period of
$16 weeks. A rapid phenotypic change of the hepato-
cytes at the beginning of replication from senescence or
crisis period was observed (Block et al., 1996). Under
these conditions, some of the hepatocytes from senes-
cence culture developed a slightly elongated morphol-
ogy and began to form colonies which were initially
FIG. 1. Phenotypic changes of HCV core gene-transfected primary
human hepatocytes after senescence. Transfected cells grown on
collagen-coated plates displayed a dramatically altered phenotype at
the end of the senescence period and had a slightly elongated mor-
phology surrounded by a number of small round dead cells under
phase-contrast microscopy (A). The immortalized cells then exhibited a
change in phenotype to epithelial-like cells within 7 days (B) and were
able to achieve greater confluency within another 1–2 weeks (C).surrounded by a number of small round dead cells (Fig.
1A). Within a week, as some of the hepatocytes contin-
e
mued to degenerate, 20–50 small colonies exhibiting a
morphology more closely resembling epithelial cells
were observed (Fig. 1B). These cells (passage 8) grad-
ually increased in confluency and grew within 1–2 weeks
as stable cell lines (Fig. 1C). In our hands, the transfected
hepatocytes of two donors survived, while cell lines from
one donor were lost due to contamination of the cell
culture. Illustrations of negative control cells were not
included as they did not recover from the senescence
period and did not progress further. Cellular senescence
is characterized by a decline in sensitivity to growth
factors resulting in the cessation of cell growth. Replica-
tive senescence is believed to represent a tumor sup-
pression mechanism that the aspiring tumor cell must
overcome in order to achieve an immortal state. Growth
beyond the replicative senescence checkpoint corre-
lates well with genetic lesions that interfere with one or
more of the key cellular mortality pathways (Bishop,
1991). The expression of HCV core protein appears to
result in the establishment of hepatocytes with an unlim-
ited proliferative potential or an immortalization pheno-
type as the negative control plasmid DNAs failed to
exhibit a recovery of cell growth. Cells transfected with
HCV core alone exhibited focus-forming morphology at a
frequency of 5–8 3 1024. Colonies of cells which sur-
ived after senescence were trypsinized, pooled to avoid
rtifact arising from clonal analysis, and subcultured to
evelop cell lines. The majority of these cells (.70%)
urvived serial passage. HCV core-transfected hepato-
ytes exhibited a population doubling time of between
.4 and 0.6 per day after passage 8.
ecretion of liver-specific protein by hepatocyte
ransfectants
To determine whether the hepatocytes retained func-
ions under the culture conditions after transfection with
CV core gene, we examined the expression of genes
hose protein products are cell/tissue type-specific and
re considered hallmarks of the hepatocyte phenotype.
dult hepatocytes synthesize a variety of serum proteins
uch as albumin, glucose-6-phosphatase, and a1-anti-
trypsin (A1AT), whereas a-fetoprotein is a major product
f fetal hepatocytes (Derman et al., 1991; Isom and
trom, 1992). Albumin secretion by the immortalized
epatocytes was confirmed by Western blot analysis
Fig. 2). An SV40 T-antigen-immortalized human hepato-
yte cell line (THLE5B) was used as a positive control,
nd cells of nonhepatocyte origin, such as human em-
ryonic lung epithelial (L-132) and baby hamster kidney
BHK) cells, were used as negative controls in this assay.
lucose-6-phosphatase activity was also observed in
CV core-transfected hepatocytes (data not shown). Im-
ortalized hepatocytes under similar conditions, how-ver, did not exhibit a detectable expression of A1AT
RNA or a-fetoprotein from an early stage of establish-
h
p
c
o
t
m
e
m
n
c
i
w
e
199HCV CORE PROTEIN IMMORTALIZES HUMAN HEPATOCYTESment. The absence of A1AT may be due to the culture
medium conditions (Wu et al., 1994) or the development
of a transformed phenotype, as suggested earlier with
the loss of differentiated markers in SV40-transformed
hepatocytes (Woodworth et al., 1988). The lack of a-feto-
protein expression is not unexpected from an estab-
lished cell line, as this indicates that they may be derived
from differentiated hepatocytes (Pfeifer et al., 1993). HCV
core gene-transfected stable cell lines did not exhibit the
presence of smooth muscle actin, suggesting the ab-
sence of stellate cells in the immortalized cell popula-
tion.
HCV core gene expression in hepatocyte
transfectants
Total RNA was extracted from HCV core gene-trans-
fected hepatocytes and from negative control THLE5B
cells. Extracted RNA was tested for HCV core-specific
mRNA expression by RT-PCR using specific primers.
Stable hepatocyte transfectants exhibited HCV core-spe-
cific mRNA expression, and the negative control RNA did
not show a detectable HCV core-specific amplified prod-
uct (Fig. 3A). GAPDH was used as an internal control and
revealed the presence of RNA in all samples tested (not
shown). Western blot analysis of cell lysates using a
specific monoclonal antibody, C7-50, followed by chemi-
luminescence also exhibited core protein expression as
a major band of ;22 kDa. This polypeptide band was
present only in stable core transfectants established
FIG. 2. Albumin secretion in the culture fluid from immortalized
uman hepatocytes by Western blot analysis. Results from THLE5B
ositive control (lane 1), HCV core-transfected immortalized hepato-
ytes (lane 2), and L-132 (lane 3) and BHK (lane 4) cells of nonhepatic
rigin as the negative controls are shown. An arrow on the left shows
he position of the ;65-kDa albumin band detected from the culture
supernatant. Molecular weight of the protein band was ascertained
from positions of prestained molecular weight markers (BRL).from the primary hepatocytes (Fig. 3B). HCV core gene
transfectants demonstrated distinct periplasmic localiza-tion of the core protein by indirect immunofluorescence
using a core-specific monoclonal antibody, C7-50 (Fig. 4).
Core gene expression in the immortalized hepatocytes
was detected at a number of passage levels by RT-PCR,
Western blot analysis, and indirect immunofluorescence
starting from passage 8 (when cells were stable after
senescence) up to passage 40. We cannot conclude at
this time whether persistent production of core protein is
necessary for the maintenance of the immortalized state
of these cells and will await further in-depth analysis.
Telomerase activity in immortalized hepatocytes
Telomerase is a ribonucleoprotein that synthesizes
telomeric DNA repeats onto the ends of chromosomes.
More than 85% of human cancers express telomerase
FIG. 3. (A) RT-PCR amplification of HCV core-specific mRNA from
HCV core-transfected immortalized primary human hepatocytes of two
different sets (lanes 1 and 2), SV40 T-antigen-immortalized THLE5B
hepatocytes as a negative control (lane 3), and core plasmid DNA (lane
4) as a positive control is shown. The position of the f X174HaeIII DNA
arker (M) is shown on the left. (B) Detection of HCV core protein
xpression by Western blot analysis using two different pools of im-
ortalized human hepatocytes (lanes 1 and 2) and THLE5B as a
egative control (lane 3). All lanes were edited from the same blot. HCV
ore-immortalized cells exhibited a major polypeptide of ;22 kDa as
ndicated by the arrow on the left. Molecular weight of the protein band
as ascertained from positions of prestained molecular weight mark-
rs (BRL).
FIG. 4. Predominant periplasmic expression of HCV core protein in
immortalized human hepatocytes (A) and untransfected primary hepa-
tocytes as a negative control (B) was detected by immunofluorescence
using a monoclonal antibody to the core protein.
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200 RAY, MEYER, AND RAYactivity and a large proportion of human hepatocellular
carcinomas are positive. Either oncogene activation or a
loss of tumor suppressor function is the probable mech-
anism by which the strict repression of the telomerase
reverse transcriptase component in primary somatic
cells is overridden (Greenberg et al., 1999). Cell extracts
from human epithelial cervical carcinoma (HeLa) cells as
a positive control and human foreskin fibroblasts (HFF)
as a negative control, along with the HCV core gene-
transfected immortalized human hepatocytes, were used
to measure the telomerase activity (Fig. 5A). Stable he-
patocyte transfectants with HCV core gene at passage 8
exhibited distinct telomeres as observed with other pos-
itive control HeLa cells. These telomeres were observed
to be elongated as the passage number of the trans-
fected cells was increased from 8 to 15 to 40 (Fig. 5B).
Each passage number corresponds to ;7 days culture
fter passage 8. However, telomerase activity was not
etected in the mock-transfected primary human hepa-
ocytes (PH), collected after 7 days of transfection. Since
H did not replicate for longer time, cell extracts from the
arly stage of the culture were used in this assay. These
esults suggested that telomerase is reactivated in core
rotein-immortalized primary human hepatocytes imme-
iately after senescence (passage 8).
nchorage-independent growth
Anchorage-independent growth in a semisolid me-
ium of soft agar is a strong indicator of the transformed
henotype (Hamburger and Salmon, 1980). Thus, we
ested whether cells immortalized following transfection
ith the HCV core gene might take on any characteris-
ics associated with anchorage-independent growth in a
oft-agar assay. Immortalized hepatocytes from passage
did not exhibit a strong growth on soft agar, exhibiting
small number of colonies. In contrast, the immortalized
ells when tested at passages 15 and 40 grew on soft
gar as microscopically visible colonies within 4 weeks
f seeding. The typical morphology of cells grown on soft
gar is shown in Fig. 6. These results suggest that
nchorage independence is associated with cell lines
aving an established replicative turnover.
DISCUSSION
Human cells are refractory to establishment and spon-
aneous immortalization of normal human cells in vitro is
n extremely rare event. Primary hepatocytes have a
imited life span in culture. Immortalization of primary
uman hepatocytes following the introduction of HCV
ore gene and an associated telomerase activity imme-
iately after senescence, characteristic of an immortal-
zed phenotype, was evident from our studies. It is pos-
ible that the presence of core protein is necessary ateast up to passage 8 for immortalization. The mecha-
ism by which cells bypass senescence and becomeFIG. 5. Telomerase activity in positive and negative control cells of
human origin and in HCV core-transfected primary human hepato-
cytes (TPH1). Lysis buffer (LB), in the absence of cell extracts, was
also used as a negative control. The enzyme activity in positive
(HeLa) and negative (HFF) control cells (A) and at different stages of
cell passage (B) is shown. Lanes are marked on top for cells (HeLa,
HFF, TPH1) or hepatocyte cell passage number (TPH1 passage 8,
15, and 40). PH indicates mock-transfected primary human hepato-
cytes after 7 days of transfection and HI indicates heat-inactivated
samples analyzed for telomerase activity. “1” denotes heat-
inactivated samples and “2” denotes samples without heat treat-
ment.
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201HCV CORE PROTEIN IMMORTALIZES HUMAN HEPATOCYTESimmortalized is still an open question (Sedivy, 1998).
Immortalization of human cells requires the reactivation
of the telomere-lengthing enzyme, telomerase (Greider
and Blackburn, 1985; Harley, 1991), as the maintenance
of telomeres is required for cells to escape from replica-
tive senescence and proliferate indefinitely (Counter et
al., 1992). It is possible that the cells will be irretrievably
committed to growth once the telomerase is activated.
Normal cells have a strictly limited growth potential and
remain senescent after a defined number of population
doublings. In contrast, tumor cells often exhibit an ap-
parently unlimited proliferative potential and are termed
immortalized. A variety of viral proteins have been re-
ported to immortalize cells, suggesting that multiple
mechanisms may lead to an escape from senescence. It
is likely that some components in the signal transduction
pathway(s) are not expressed or are not functioning in
the senescent cell. Immortalization is an early event in
malignant transformation. The introduction of immortal-
izing genes may provide functions that are inactive in the
senescent cells or possibly overcome in some manner
the effects of growth-suppressing activities in senescent
cells (Linder and Marshall, 1990).
A recent finding of de novo hepatocellular carcinoma
with recurrent HCV and cirrhosis, 7 years after ortho-
tropic liver transplantation, reiterates the oncogenic po-
tential of HCV (Saxena et al., 1999). Hepatic steatosis
ccurs at a high rate in chronic hepatitis C patients, even
n those with cirrhosis, and a close relationship between
he presence of steatosis and intrahepatic core protein
as been noted (Fujie et al., 1999). A defective viral
enome has been observed to arise from deletions or
utations in HCV persistently infected cells (Ruster et al.,
996; Shimizu et al., 1997; Yeh et al., 1997). HCV often
FIG. 6. Phenotypic properties of the immortalized primary human
hepatocytes following transfection with core gene. Immortalized hepa-
tocytes from passage 15 were grown on soft agar. The typical anchor-
age-independent growth and colony formation of cells from passage 15
after 4 weeks on soft agar are shown.causes persistent infection and there is no evidence that
the HCV genome integrates in infected cells. Cell cycle
w
lprogression is inhibited in productively infected cells and
most infected cells are eventually killed as the virus
completes its replication cycle. However, if cell growth is
induced by a nonproductive infection, the continued
presence of viral gene products would likely be detri-
mental for host cells.
A virus can initiate potentially oncogenic events by a
number of different mechanisms. The ability of the core
protein to alter the growth properties of primary human
hepatocytes is consistent with the results from our and
other studies which examined the effect of core protein
upon the growth of cells of nonhepatic origin (Ray et al.,
1996b; Chang et al., 1998; Tsuchihara et al., 1999). Our
arlier experiment with primary rat embryo fibroblasts
Ray et al., 1996b) suggested that core protein along with
cooperative H-ras oncogene may transform cells into
n immortalized and tumorigenic phenotype. A similar
bservation was noted using a subclone of an estab-
ished murine fibroblast (BALB/3T3 A31-I-1) which is rel-
tively resistant to ras-induced transformation and re-
uires the presence of another oncogene (Tsuchihara et
l., 1999). Chang et al. (1998) also performed similar
ork, as we reported earlier, using primary REF cells.
nder their experimental conditions, primary REFs did
ot exhibit focus formation and failed to survive. The
eason for this discrepancy is unclear and may arise
rom a number of factors as already discussed (Chang et
l., 1998), including minor amino acid changes in the
CV core protein from different virus strains used. It is
lso important to note that in our earlier study a predom-
nant nuclear localization of the core protein was ob-
erved upon cotransfection of REF cells with core and a
ooperative oncogene. However, in this study or in an
arlier study using core-transfected HeLa cells (Ray et
l., 1996a), a predominant perinuclear localization of the
ore protein was observed. Use of two distinct cell types
REFs and epithelial cells) and different experimental
onditions could be possible reasons for this difference
nd will need further investigation. The possibility that
he core protein functions may arise from overexpression
f the transfected gene cannot be ruled out. However,
verexpression does not appear to be a determining
actor in this case as REF cells transfected with the same
lasmid and a c-myc cooperative oncogene did not gen-
rate immortalize phenotype even though a similar level
f core protein expression was apparent (Ray et al.,
996b). The core protein expression level in transfected
ells may have an impact on the magnitude of the effect
ithout altering the functional activity of this viral protein.
Hepatocarcinogenesis involves alterations in the con-
erted action of proto-oncogenes, growth factors, and
umor suppressor genes. The effects of HCV core protein
ight result either from direct or indirect activation of
ransgene expression or from an independent pathwayhich leads to an alteration in hepatocyte turnover. It is
ikely that the core protein contributes directly to the
n
b
f
n
o
u
1
s
r
w
t
a
m
a
t
P
p
n
w
c
t
H
n
a
c
202 RAY, MEYER, AND RAYproliferation of infected host cells and malignant cells
may arise from immortalized hepatocytes. The lack of a
suitable cell culture system and small animal model for
HCV infection makes it difficult to understand virus rep-
lication and the pathogenesis of HCV-related disease.
However, as other HCV proteins (NS3 and NS5A) have
also been implicated in HCV persistence and pathogen-
esis (Sakamuro et al., 1995; Gale et al., 1999; Ghosh et
al., 1999), it is difficult to correlate the functional effect of
core protein when expressed together with the other
proteins of the virus. However, the results presented
here clearly establish a cell growth regulatory role for the
core protein in primary human hepatocytes, a natural
host for HCV. The capacity to immortalize primary human
hepatocytes will provide a valuable model for studying
the regulation of hepatocyte proliferation-related phe-
nomena by the HCV core gene and associated factors,
as they may relate to multistage hepatocarcinogenic
events.
MATERIALS AND METHODS
Cells and plasmids
Normal human hepatocytes prepared by a collage-
nase/dispase perfusion of three adult autopsy donors
with no clinical evidence of cancer and an absence of
antibodies to hepatitis A, B, and C viruses, and HIV, were
obtained from two different sources (Human Cell Culture
Center, Inc., Woodbine, GA, and Clonetics, San Diego,
CA). Cells seeded on collagen type I-coated plates were
delivered by a special carrier within 24 h of cell harvest.
Medium of the cell culture plate was changed with he-
patocyte maintenance medium (Clonetics, San Diego)
and incubated overnight at 37°C. CMV-Core (amino ac-
ids 1–191), an antisense orientation of the core, or
pcDNA3 empty vector plasmid was used for transfection
of hepatocytes in this study. The plasmids were derived
as described earlier (Ray et al., 1996b) from a partial
cDNA clone of HCV 1a (Blue4/C5p-1), kindly provided by
Dr. Michael Houghton (Chiron Corp., CA). A nonneoplas-
tic human hepatocyte cell line (THLE5B), generated by
transfection of primary human liver epithelial cells with
SV40 T antigen (Pfeifer et al., 1993), was kindly provided
by Dr. Curtiss C. Harris (National Cancer Institute, MD)
and was used as a control cell line when needed.
Transfection and maintenance of hepatocytes
Cells were transfected with HCV core plasmid, the
antisense orientation of the core, or an empty vector
using strontium phosphate as described earlier (Brash et
al., 1987; Pfeifer et al., 1993). Briefly, cells plated over-
ight were refed with fresh culture medium 2 to 4 h
efore transfection. HCV core gene (1 mg) was trans-ected with 18–19 mg of carrier salmon sperm DNA. For
egative control, a plasmid containing the antisenserientation of the plasmid or empty vector DNA was
sed. The cells were washed and fed with fresh medium
.5 h posttransfection, refed every 2 to 3 days, and pas-
aged at a 3- to 4-day intervals for ;20 days. An en-
iched PFMR-4 medium (Biofluids, MD) supplemented
ith EGF, transferrin, retinoic acid, bovine pituitary ex-
ract, glutamine, insulin, hydrocortisone, T3, P/E stock,
nd gentamicin or a defined culture medium supple-
ented with growth factors and antimicrobials for small
irway epithelial cell growth (SAGM; Clonetics, CA) was
ested for hepatocyte growth. In our hands, enriched
FMR-4 or SAGM exhibited similar hepatocyte growth
rofiles (as also observed in control THLE5B cells). The
umber of proliferative foci in transfected hepatocytes
as determined 16–20 weeks after transfection. Pooled
olonies from transfected cells were recovered by
rypsinization (0.025% trypsin containing 0.01% EDTA in
BSS; Clonetics), followed by treatment with trypsin-
eutralizing solution (Clonetics). Cells were centrifuged
nd transferred to fresh collagen-coated plates and in-
ubated with culture medium for growth at 33°C in a CO2
incubator.
Test for hepatocyte markers
Albumin secretion by hepatocytes in the culture me-
dium was examined by Western blot analysis. Culture
fluid from cells grown in serum-free medium (3 ml from a
72-h culture of ;106 cells/ml) was mixed with 23 loading
buffer and subjected to SDS–PAGE, followed by transfer
onto nitrocellulose. Proteins on the nitrocellulose blot
were analyzed with a goat anti-human albumin peroxi-
dase conjugate (Cappel, PA) and the peroxidase signal
was detected by chemiluminescence (ECL; Amersham).
In a similar manner, expression of a-fetoprotein in the
cell lysates was analyzed using a specific goat antibody
(Cappel) by Western blot analysis. Expression of A1AT
was analyzed by blot hybridization of cytoplasmic RNA
extracted from nearly confluent cultures. A 540-nucleo-
tide radiolabeled antisense RNA probe corresponding to
the 39 end of mouse A1AT mRNA, known to cross-hybrid-
ize with human A1AT RNA, was used for detection of
mRNA. The activity of glucose-6-phosphatase in the cell
homogenate was measured using a microtechnique
modified from Bruchell et al. (1988). Western blot analysis
of cell lysates with antibody to smooth muscle actin
(Sigma Chemical Company, MO) was performed to ex-
amine the marker for cells of primary hepatic stellate
origin as already described (Brown et al., 1997). A posi-
tive control of hepatic stellate cells was included in this
assay.
Detection of HCV core gene expression
Total RNA was isolated from hepatocytes and sub-
jected to RT-PCR as already described (Ray et al., 1998).
HCV core-specific sequences were amplified (amino ac-
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203HCV CORE PROTEIN IMMORTALIZES HUMAN HEPATOCYTESids 102 to 160) from reverse-transcribed RNA (cDNA) by
PCR using HCV core sequence-specific primers (sense
59GGCTCTCGGCCTAGCTGG39 and antisense 59CTTC-
CAGAATTCGGACGCCAT39). The amplified DNA was an-
lyzed by 1.5% agarose gel electrophoresis. Core protein
xpression was separately examined by Western blot
nalysis (Ray et al., 1996a) using a specific murine mono-
clonal antibody, C7-50 (Moradpur et al., 1996), kindly
provided by Dr. Jack R. Wands (Harvard Medical School,
MA). An anti-mouse immunoglobulin coupled with horse-
radish peroxidase was used as the second antibody to
detect HCV core protein by chemiluminescence (ECL;
Amersham). Stable hepatocyte transfectants were also
tested for expression of HCV core protein by indirect
immunofluorescence. Briefly, cells were treated with 1%
formaldehyde for 30 min at room temperature. After be-
ing washed, cells were incubated with ethanol/acetic
acid (90/10) for 1.5 min at 4°C. Cells were washed and
treated with a HCV core protein-specific monoclonal
antibody, C7-50. A second antibody, anti-mouse Ig con-
jugated to fluorescein isothiocyanate, was used for de-
tection of the core protein by fluorescence microscopy.
Telomerase assay
Telomerase activity was detected by a PCR-based
telomerase-repeat amplification protocol (TRAP) as de-
scribed earlier (Bryan et al., 1995; N. W. Kim et al., 1994).
Cell lysates were prepared from 105 cells using CHAPS
detergent buffer and the protein concentrations of the
cellular extracts were determined using a commercially
available assay kit (Bio-Rad). CHAPS cell extracts were
incubated in the presence of four dNTPs at 50 mM each,
03 TRAP buffer (N. W. Kim et al., 1994), [g-32P]ATP-
abeled 0.1 mg TS primer (59AATCCGTCGAGCAGTT39), 1
mg of T4g32 protein (Roche), 0.1 mg of CX primer
59[CCCTTA]3 CCCTAA39), and 2 U of Taq DNA polymer-
ase in a 50-ml reaction volume. Lysis buffer without cell
extracts or heat-inactivated cell extracts were used as
the negative controls. After extension of TS primer by
telomerase for 30 min at 30°C, tubes were transferred to
a thermocycler for amplification of 27 cycles at 94°C for
30 s, 50°C for 30 s, and 72°C for 1.5 min. One-half of the
reaction was analyzed by electrophoresis on a 12.5%
native polyacrylamide (19:1) gel in 0.53 TBE. The gel
was exposed to X-ray film at 270°C for autoradiography.
Soft-agar assay
Transfected cells were tested for anchorage-indepen-
dent growth and proliferative foci formation on soft agar
as described earlier (Ray et al., 1996b). Cells were ex-
amined over an incubation period of 6 weeks to deter-
mine colony formation. Colonies exceeding ;0.1 mm in
diameter were considered positive.ACKNOWLEDGMENTS
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